Optiver Holding’s Sanofi SNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$18.8M Buy
440,900
+176,600
+67% +$7.89M 0.01% 340
2026
Q1
$12.7M Buy
264,300
+83,400
+46% +$3.89M ﹤0.01% 331
2025
Q4
$8.77M Sell
180,900
-85,900
-32% -$4.26M ﹤0.01% 344
2025
Q3
$12.6M Buy
266,800
+103,400
+63% +$4.99M 0.01% 266
2025
Q2
$7.89M Buy
163,400
+15,400
+10% +$787K ﹤0.01% 190
2025
Q1
$8.21M Buy
148,000
+125,900
+570% +$6.81M ﹤0.01% 184
2024
Q4
$1.07M Buy
+22,100
New +$1.12M ﹤0.01% 381

Other funds holding SNY

Optiver Holding's SNY Position: Q2 2026 in Review

Optiver Holding reduced its Sanofi (SNY) stake by 77% in Q2 2026, selling an estimated $16.9M and leaving 115,761 shares worth $4.94M. The position accounts for ﹤0.01% of the portfolio, ranked #463.

Optiver Holding first reported a position in SNY in Q4 2021 and has held it in 15 quarters since. The position peaked at $38.6M in Q2 2023. 715 funds tracked by Wall St. Rank hold SNY as of Q2 2026.

  • Optiver Holding held 115,761 shares of Sanofi worth $4.94M as of Q2 2026.
  • Optiver Holding sold 378,068 Sanofi shares in Q2 2026, an estimated $16.9M.
  • Sanofi made up ﹤0.01% of Optiver Holding's portfolio in Q2 2026, its #463 holding.
  • Optiver Holding first reported a position in Sanofi in Q4 2021 and has held it in 15 quarters since.
  • Optiver Holding's Sanofi position peaked at $38.6M in Q2 2023.
  • 715 funds tracked by Wall St. Rank held Sanofi as of Q2 2026.

Based on Optiver Holding's 13F filing for Q2 2026, filed 12 Aug 2026.